Financials Clearday, Inc.

Equities

CLRD

US1847911013

Healthcare Facilities & Services

Market Closed - OTC Markets 02:14:50 2024-04-26 pm EDT 5-day change 1st Jan Change
0.59 USD -4.84% Intraday chart for Clearday, Inc. +14.56% -35.87%

Valuation

Fiscal Period: December 2021 2022
Capitalization 1 30.72 10.67
Enterprise Value (EV) 1 80.1 55.53
P/E ratio -1.11 x -0.47 x
Yield - -
Capitalization / Revenue 2.39 x 0.85 x
EV / Revenue 6.22 x 4.45 x
EV / EBITDA -5.62 x -4.89 x
EV / FCF -11,186,507 x 14,835,715 x
FCF Yield -0% 0%
Price to Book -0.64 x -0.18 x
Nbr of stocks (in thousands) 14,914 19,045
Reference price 2 2.060 0.5600
Announcement Date 4/15/22 5/25/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022
Net sales 1 12.5 12.66 12.88 12.49
EBITDA 1 -8.124 -12.7 -14.24 -11.35
EBIT 1 -8.7 -13.3 -14.77 -11.85
Operating Margin -69.61% -105.12% -114.66% -94.91%
Earnings before Tax (EBT) 1 -9.56 -14.89 -21.98 -14.46
Net income 1 -7.164 -11.78 -19.69 -14.31
Net margin -57.32% -93.08% -152.82% -114.57%
EPS 2 -25.44 -17.31 -1.854 -1.195
Free Cash Flow - -2.304 -7.16 3.743
FCF margin - -18.2% -55.58% 29.97%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 5/14/21 5/14/21 4/15/22 5/25/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022
Net Debt 1 42.9 44.7 49.4 44.9
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) -5.276 x -3.519 x -3.467 x -3.953 x
Free Cash Flow - -2.3 -7.16 3.74
ROE (net income / shareholders' equity) - 292% 153% 56.4%
ROA (Net income/ Total Assets) - -12.9% -18% -18.5%
Assets 1 - 91.33 109.1 77.54
Book Value Per Share 2 -9.300 -19.40 -3.230 -3.050
Cash Flow per Share 2 4.070 0.9000 0.0600 0.0100
Capex 1 2.06 0.19 0.24 0.03
Capex / Sales 16.5% 1.53% 1.87% 0.23%
Announcement Date 5/14/21 5/14/21 4/15/22 5/25/23
1USD in Million2USD
Estimates
  1. Stock Market
  2. Equities
  3. CLRD Stock
  4. Financials Clearday, Inc.